Windtree Therapeutics, Inc. (WINT)
NASDAQ: WINT · IEX Real-Time Price · USD
3.610
-0.120 (-3.22%)
Jul 22, 2024, 10:42 AM EDT - Market open
Windtree Therapeutics Employees
Windtree Therapeutics had 20 employees as of December 31, 2022. The number of employees decreased by 13 or -39.39% compared to the previous year.
Employees
20
Change (1Y)
-13
Growth (1Y)
-39.39%
Revenue / Employee
n/a
Profits / Employee
-$298,050
Market Cap
2.14M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Nuwellis | 59 |
cbdMD | 52 |
NovaBay Pharmaceuticals | 26 |
Azitra | 10 |
Phio Pharmaceuticals | 9 |
Tivic Health Systems | 9 |
Galmed Pharmaceuticals | 8 |
Quoin Pharmaceuticals | 4 |
WINT News
- 2 months ago - Windtree Therapeutics Regains Compliance with Nasdaq - GlobeNewsWire
- 3 months ago - What made Windtree Therapeutics stock tank 20% on Monday? - Invezz
- 3 months ago - Windtree Therapeutics Announces Reverse Stock Split - GlobeNewsWire
- 3 months ago - Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates - GlobeNewsWire
- 3 months ago - Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing - GlobeNewsWire
- 6 months ago - Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a Research - GlobeNewsWire
- 6 months ago - Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives - GlobeNewsWire
- 6 months ago - Windtree Therapeutics (NASDAQ:WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company - Accesswire